e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Discussion of vaccines, biomarkers and risk factors analysis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands
S. Vestjens (Nieuwegein, Netherlands)
Source:
International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Session:
Discussion of vaccines, biomarkers and risk factors analysis
Session type:
Poster Discussion
Number:
4508
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Vestjens (Nieuwegein, Netherlands). Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands. 4508
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia
Source: Eur Respir J 2010; 36: 1073-1079
Year: 2010
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Prognostic score systems and community-acquired bacteraemic pneumococcal pneumonia
Source: Eur Respir J 2006 Oct 01;28(4):816-823
Year: 2006
Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP)
Source: Eur Respir J 2005; 26: Suppl. 49, 639s
Year: 2005
MRSA as a cause of community-acquired pneumonia
Source: Eur Respir J 2009; 34: 1013-1014
Year: 2009
A study of the prevalence of streptococcus pneumoniae serotypes in patients hospitalised for community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009
Clinical features of adults with seven-valent- conjugated-vaccine- serotype pneumococcal pneumonia
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013
Epidemiology of community-acquired pneumonia and nosocomial pneumonia
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Bacterial community-acquired pneumonia
Source: Eur Respir Monogr 2014; 66: 98-111
Year: 2014
Bacteraemic pneumococcal pneumonia and SARS-CoV-2 pneumonia: differences and similarities
Source: Virtual Congress 2021 – Pneumonia
Year: 2021
Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults
Source: Eur Respir J 2003; 21: 209-214
Year: 2003
The lung bacterial microbiome in community-acquired and nosocomial pneumonia
Source: Eur Respir Monogr 2019; 83: 188-194
Year: 2019
Bacterial infections and community-acquired pneumonia in children
Source: Annual Congress 2011 - Paediatric Year in Review
Year: 2011
Use of polyvalent antigenic complex for prophylaxis of community-acquired pneumonia and respiratory infections among recruits of Russia
Source: Annual Congress 2006 - Epidemiological aspects of lung tumors and infections including tuberculosis
Year: 2006
Characteristics of patients with serotype 5 pneumococcal pneumonia
Source: Virtual Congress 2020 – Clinical challenges in pneumonia
Year: 2020
Influenza vaccination is associated with reduced severity of community-acquired pneumonia
Source: Eur Respir J 2011; 37: 147-153
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept